retatrutide developer eli lilly Preparing Applications After Positive Weight-Loss Data The retatrutide drug is manufactured

Sources: Novo Nordisk

Patients considering GLP-1 therapy should inform their endocrinologist or primary care provider, as thyroid function monitoring may need to be intensified during periods of significant weight loss

Show Sources SOURCES: Photo Credit: iStock/Getty Images StatPearls [Internet] : "Compare and Contrast the Glucagon-Like Peptide-1 Receptor Agonists (GLP1RAs)." Diabetes, Obesity, and Metabolism : "Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies." Society of Behavioral Medicine: "What are GLP-1 Medications

In both roles, we act as a coordination and administrative platform